Source: Breathe 2008; 4: 377-380



Rating:

Share or cite this content

Citations should be made in the following way:
Alpha 1-antitrypsin deficiency. Breathe 2008; 4: 377-380

Member's Comments

No comment yet.

Related content which might interest you: Phase I safety investigation of an aerosolized, recombinant alpha 1-antitrypsin in subjects with alpha 1-antitrypsin deficiency Source: Eur Respir J 2004; 24: Suppl. 48, 228s Year: 2004 COVID-19 infection in Severe Alpha 1-antitrypsin deficiency: looking for a rationale Source: Virtual Congress 2021 – Burden and epidemiology of COVID-19 Year: 2021 Circulating polymers in ?1-antitrypsin deficiency Source: Eur Respir J 2014; 43: 1501-1504 Year: 2014 Diagnosing alpha 1-antitrypsin deficiency: how to improve the current algorithm Source: Eur Respir Rev 2015; 24: 52-57 Year: 2015 Alpha 1 antitrypsin (A1AT) deficiency in children with asthma in Brazil Source: Eur Respir J 2003; 22: Suppl. 45, 499s Year: 2003 Alpha 1-Antitrypsin deficiency (AATD) in patients with ARDS consequent to SARS-CoV-2 infection. Source: Virtual Congress 2021 – COVID – 19: treatments and predictive factors Year: 2021 Alpha 1 - antitrypsin deficiency: diagnosis and treatment Source: Virtual Congress 2021 – Alpha 1 - antitrypsin deficiency: diagnosis and treatment Year: 2021 Alpha 1 antitrypsin (A1AT) deficiency among patients with cystic fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 501s Year: 2003 A case report of alpha 1-antitrypsin deficiency in a six-month infant Source: Eur Respir J 2004; 24: Suppl. 48, 228s Year: 2004 Clinical features of alpha one antitrypsin deficiency in COPD Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 Alpha 1-globulin fraction of serum protein electrophoresis for screening and early detection of alpha 1 antitrypsin deficiency Source: International Congress 2018 – Airway disease: recent discoveries Year: 2018 Alpha-1 antitrypsin deficiency severity and the risk of COVID-19 Source: Virtual Congress 2021 – Burden and epidemiology of COVID-19 Year: 2021 Reduction in incidence of exacerbations in patients with alpha 1 antitrypsin deficiency (A1ATD) treated with concentrates of alpha 1 antitrypsin (A1AT): REXA study Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 Alpha-1 antitrypsin deficiency – a potentially fatal disease Source: International Congress 2017 – Rare and common genetic variants of common and rare airway diseases Year: 2017 Inhalation of α 1-protease inhibitor (α 1-Pi): influence on the protease-antiprotease balance in the epithelial lining fluid (ELF) of patients with α 1-Pi deficiency Source: Eur Respir J 2001; 18: Suppl. 33, 249s Year: 2001 Clinical and functional characteristics of Italian and Spanish patients with alpha 1-antitrypsin deficiency Source: Annual Congress 2012 - COPD: epidemiology and varia Year: 2012 Estimated numbers and prevalence of PI*S and PI*Z deficiency alleles of α1-antitrypsin deficiency in Asia Source: Eur Respir J 2006; 28: 1091-1099 Year: 2006